Kuria Therapeutics, Inc.
Developing novel NRF2 activators to improve mitochondrial function, resolve oxidative stress, and suppress inflammation in diseases of the eye and skin.
)
January 11-14, 2027 | San Francisco Marriott Marquis
January 15, 2027 | Virtual
January 11-14, 2027 | San Francisco
January 15, 2027 | Virtual
)
)
January 11-14, 2027 | San Francisco Marriott Marquis
January 15, 2027 | Virtual
January 15, 2027 | Virtual
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)